Opendata, web and dolomites

LUCINE SIGNED

LUCINE: THE COMPREHENSIVE, PERSONALIZED AND SAFE eHEALTH SOLUTION THAT ACCURATELY MEASURES, ANALIZES AND RELIEVES PAIN

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LUCINE project word cloud

Explore the words cloud of the LUCINE project. It provides you a very rough idea of what is the project "LUCINE" about.

22    impacts    provides    movements    nition    personal    public    becomes    appointments    solution    phenomenon    facial    digital    pharmacy    primary    45    immersive    collected    habits    postural    environment    offers    clinically    validated    first    pandemic    not    tools    million    daily    culture    smartphone    mobile    relieve    customized    company    patients    healthcare    market    attitudes    diagnosis    economic    sufferfrom    environmental    global    revolutionary    limit    world    subjective    innovator    approximately    recog    350    facets    treatment    seconds    quality    physicians    vocal    europeans    utilises    microphone    lucine    billion    lack    consults    interfering    professionals    pain    vr    solutions    accounts    dramatic    adult    care    data    time    person    relies    health    levels    adversely    profile    represented    variety    adapts    social    camera    gt    chronic    life    illness    expectations    personalised    patient    441    tastes    individuals   

Project "LUCINE" data sheet

The following table provides information about the project.

Coordinator
LUCINE SAS 

Organization address
address: 2 PLACE DE LA BOURSE
city: BORDEAUX
postcode: 33000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUCINE SAS FR (BORDEAUX) coordinator 50˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

LUCINE is a revolutionary, clinically validated, solution for chronic pain diagnosis and management. Chronic pain is a global pandemic that affects 100 million Europeans. The management of pain is not adapted to the needs of the patients or the expectations of health professionals. When it becomes chronic, pain becomes an illness and has dramatic social, economic and public health impacts. Each year, approximately 1 in 5 Europeans are affected by chronic pain. Chronic pain adversely affects patient’s quality of life and can even limit a person’s movements, further interfering with daily activities. Health professionals lack the time and the tools to address a phenomenon as personal and subjective as pain. Still, chronic pain accounts for 22% of primary care physicians consults, with over a third of adult appointments involving a patient in chronic pain. The cost of pain at the European level can be estimated at € 441 billion. As a company, LUCINE is a leading innovator on pain diagnosis and management. LUCINE ́s customized mobile application is the first digital solution that can measure and analyse all facets of a patient’s pain, in 45 seconds. It utilises the smartphone’s camera and microphone to measure a patient’s pain levels through facial, postural, vocal and environmental recog¬nition. It provides an objective measurement of the patient’s pain level on a scale of 1 to 100. Moreover, LUCINE is the first “digital pharmacy” that offers personalised immersive healthcare solutions to relieve pain. Yet it relies on existing “devices” (smartphone, VR sets), by offering a variety of care adapted to the environment, pain levels and patient’s profile. Based on the data collected our system adapts the treatment to the tastes, attitudes, habits, and culture of the user. LUCINE’s products are targeting a large global market of € >350 billion represented by the over 1.5 billion individuals across the world who sufferfrom this type of pain.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LUCINE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LUCINE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

MHS (2019)

Metal Hydrides Hydrogen Storage

Read More